言語を選択
新規登録

HLA-A*0201 | B2M | EW

お問い合わせ

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
RogaratinibBAY-1163877Phase 3 ClinicalBayer AGSolid tumours; Carcinoma, Transitional Cell; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Breast Neoplasms; Gastrointestinal Stromal Tumors; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung
詳細
SC-0011SC-0011Phase 3 ClinicalShijiazhuang Zhikang Hongren New Drug Development Co LtdSolid tumours; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
AUR-109ODM-203; AUR-109Phase 2 ClinicalOrion CorpOvarian Neoplasms; Liver Neoplasms; Solid tumours; Carcinoma, Renal Cell; Urinary Bladder Neoplasms; Pulmonary Fibrosis; Breast Neoplasms; Lung Neoplasms
詳細
FisogatinibBLU-554; CS-3008Phase 2 ClinicalBlueprint Medicines CorpCarcinoma, Hepatocellular
詳細
EVER-4010001EVER-4010001Phase 2 ClinicalEverNov Medicines (Zhuhai Hengqin) Co LtdSolid tumours
詳細
GunagratinibICP-192Phase 2 ClinicalBeijing Tiancheng Pharmaceutical Technology Co LtdSolid tumours; Biliary Tract Neoplasms; Head and Neck Neoplasms; Stomach Neoplasms; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Cholangiocarcinoma; Lung Neoplasms
詳細
IrpagratinibABSK-011Phase 2 ClinicalABbisko Therapeutics Co LtdSolid tumours; Liver Neoplasms; Carcinoma, Hepatocellular
詳細
BPI-43487BPI-43487Phase 1 ClinicalBetta Pharmaceuticals Co LtdBiliary Tract Neoplasms; Solid tumours; Carcinoma, Hepatocellular
詳細
HS-236HS-236Phase 1 ClinicalZhejiang Hisun Pharmaceutical Co LtdSolid tumours
詳細
HS-10340HS-10340Phase 1 ClinicalChangzhou Hengbang Pharmaceutical Co Ltd, Shanghai Hansoh Biomedical Co Ltd, Jiangsu Hansoh Pharmaceutical Group Co LtdSolid tumours
詳細
ICP-105ICP-105Phase 1 ClinicalNanjing Tianyin Jianhua Pharmaceutical Technology Co Ltd, Beijing Tiancheng Pharmaceutical Technology Co Ltd, Beijing Innocare Pharma Tech Co LtdLiver Neoplasms; Solid tumours
詳細
ZSP-1241ZSP-1241Phase 1 ClinicalGuangdong Zhongsheng Pharmaceutical Co LtdBiliary Tract Neoplasms; Liver Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma; Cholangiocarcinoma; Colorectal Neoplasms; Carcinoma, Hepatocellular
詳細
H3B-6527H3B-6527Phase 1 ClinicalH3 Biomedicine IncLiver Neoplasms; Carcinoma, Hepatocellular
詳細
SYHX-2005SYHX-2005; SYHX2005Phase 1 ClinicalCspc Ouyi Pharmaceutical Co LtdSolid tumours
詳細
JAB-6343Phase 1 ClinicalJacobio Pharmaceuticals Co LtdSolid tumours
詳細
SY-4798Phase 1 ClinicalSolid tumours
詳細
ABSK-012ABSK-012; ABSK012Phase 1 ClinicalABbisko Therapeutics Co LtdSolid tumours
詳細
LY-2874455LY-2874455Phase 1 ClinicalEli Lilly And CompanyNeoplasms; Leukemia, Myeloid, Acute
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Lenvatinib MesylateMK-7902; ER-203492-00; E-7080ApprovedEisai Co LtdKisplyx, Lenvima, Lenvima/Kisplyx, 乐卫玛United StatesThyroid NeoplasmsEisai Inc2015-02-13Neuroendocrine Tumors; Paraganglioma; Thyroid Cancer, Papillary; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Glioma; Lymphoma; Endometrial Neoplasms; Thyroid Neoplasms; Hepatic Insufficiency; Breast Neoplasms; Cholangiocarcinoma; Osteosarcoma; Solid tumours; Carcinoma, Adenoid Cystic; Adenocarcinoma, Follicular; Liver Diseases; Thyroid Carcinoma, Anaplastic; Adenocarcinoma of Lung; Neoplasms; Renal Insufficiency; Pheochromocytoma; Esophageal Neoplasms; Carcinoma, Renal Cell; Ovarian Neoplasms; Liver Neoplasms; Biliary Tract Neoplasms
詳細
FutibatinibTAS-120ApprovedTaiho Pharmaceutical Co Ltd, Otsuka Pharmaceutical Co LtdLYTGOBIUnited StatesCholangiocarcinomaTaiho Oncology Inc2022-09-30Central Nervous System Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Endometrial Neoplasms; Lymphoma; Metastatic breast cancer; Sarcoma; Cholangiocarcinoma; Breast Neoplasms; Biliary Tract Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Esophageal Neoplasms; Carcinoma; Stomach Neoplasms; Bone Marrow Neoplasms; Solid tumours
詳細
Erdafitinib890E37NHMV; G-024; JNJ-493; JNJ-42756493; TAR-210ApprovedAstex Pharmaceuticals IncBalversaUnited StatesCarcinoma, Transitional CellJanssen Biotech Inc2019-04-12Carcinoma, Squamous Cell; Histiocytosis, Langerhans-Cell; Osteosarcoma; Sarcoma; Prostatic Neoplasms; Bile Duct Neoplasms; Urologic Neoplasms; Histiocytic Sarcoma; Hepatic Insufficiency; Lymphoma; Lymphoma, Non-Hodgkin; Neuroblastoma; Glioma; Metastatic breast cancer; Carcinoma, Neuroendocrine; Carcinoma, Hepatocellular; Xanthogranuloma, Juvenile; Carcinoma, Non-Small-Cell Lung; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Adenocarcinoma; Stomach Neoplasms; Rhabdomyosarcoma; Ependymoma; Medulloblastoma; Hematologic Neoplasms; Bone metastases; Carcinoma; Rhabdoid Tumor; Hepatoblastoma; Esophageal Neoplasms; Solid tumours; Glioblastoma; Carcinoma, Transitional Cell; Neoplasms; Wilms Tumor; Urinary Bladder Neoplasms; Multiple Myeloma; Central Nervous System Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma, Ewing
詳細
  • お問い合わせ
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8